PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Thoracic Oncology, European Institute of Oncology, IRCCS, Milan, Italy Antonio.Passaro@ieo.it.\', \'University Hospital of Geneva Department of Oncology, Geneva, Switzerland.\', \'Department of Pulmonary Medicine, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.\', \'Division of Cancer Sciences, University of Manchester & The Christie NHS Foundation Trust, Manchester, UK.\', \'Department of Medical Oncology, Thoracic Unit, Gustave Roussy, Villejuif, France.\', \'Vall d\'Hebron University Hospital, Vall d\'Hebron Institute of Oncology (VHIO), Barcelona, Spain.\', \'Department of Oncology and Radiotherapy, Gdanski Uniwersytet Medyczny, Gdansk, Poland.\', \'Division of Thoracic Oncology, European Institute of Oncology, IRCCS, Milan, Italy.\', \'LungenClinic, Airway Research Center North, German Center for Lung Research, Grosshansdorf, Germany.\', \'Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.\']
?:citedBy
  • -1
?:creator
?:doi
  • e00082010.1136/esmoopen-2020-000820
?:doi
?:hasPublicationType
?:journal
  • ESMO open
is ?:pmid of
?:pmid
?:pmid
  • 32581069
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32581069>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32581069>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all